Neuropace, Inc. NPCE Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s operating cash flow?
- Neuropace, Inc. (NPCE) reported operating cash flow of -$5.9M in Q1 2026.
- How has Neuropace, Inc.'s operating cash flow changed year-over-year?
- Neuropace, Inc.'s operating cash flow increased by 21.1% year-over-year, from -$7.48M to -$5.9M.
- What is the long-term trend for Neuropace, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s operating cash flow has grown at a -17.3% compound annual growth rate (CAGR), from -$24.58M to -$11.51M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.